$EL

JPMorgan Raises Price Target for Estee Lauder (EL) Ahead of Earn

JPMorgan raised its price target for Estee Lauder (EL) to $115 and added it to its 'Catalyst Watch – Positive' list ahead of earnings. The company is modestly overvalued according to GF Value™, with a GF Score™ of 75. Insider activity shows significant net selling.

Original reporting
Published Oct 19, 2026, 12:00 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 19, 2026, 12:44 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefFinancial news
Primary signal
$EL
Bullish
high confidence
Mentioned
$EL
Relevance
7/10
AlphAI data visualization · based on gurufocus.com
Decision brief

The 30-second read

$ELBullishMed
01

Why it matters

Analyst upgrade may trigger short‑term buying pressure, but valuation concerns could limit the rally.

02

Market read

The upgrade adds a fresh catalyst ahead of earnings, offering a modest trading opportunity.

03

What to watch

Potential headwinds in China and the modest overvaluation indicated by GF Value may temper the upside.

Relevance 7/10Novelty 7/10Timing: pre‑earnings period, before November 2 release

Background

Estee Lauder trades around $104 with a trailing P/E of ~210, well above its 5‑year median, and has seen heavy insider selling over the past year.

Company-level read

Ticker impact

$ELBullishHigh confidence
Context

JPMorgan raised EL's price target to $115 and kept an Overweight rating, adding the stock to its Catalyst Watch list ahead of the November 2 earnings.

Expected impact

likely modest upside as the market prices in the higher target and positive earnings outlook

Evidence & confidence

Analyst upgrades with new price targets historically move the stock positively, especially when tied to an upcoming earnings report.

Market effects

Positive sentiment may lift other consumer‑defensive beauty stocks as investors anticipate sector‑wide earnings strength.

The upgrade could boost sentiment for U.S. large‑cap stocks ahead of the earnings season.

Limited to U.S. equity markets; no broader macro impact.

Counterpoint

The high P/E multiple and significant insider selling could signal overvaluation and downside risk despite the upgrade.

Key entities

  • JPMorgan

    Raised price target and kept Overweight rating on EL.

  • Estee Lauder Companies Inc.

    Consumer‑defensive beauty products maker, subject of the upgrade.

Related articles

$ELMed

Why is Estee Lauder stock climbing today?

Estee Lauder (EL) stock rose 2.6% in pre-market trading after Barclays upgraded it to Overweight and raised its price target to $108, citing broad recovery and strong Q4 2026 results. The company reported adjusted EPS of $0.39 and revenue of $3.63B, both beating estimates. Barclays highlighted balanced revenue growth and margin expansion potential. Bernstein SocGen maintained a Market Perform rating with a $106 target. The broader market traded modestly lower.

$ELMed

Estee Lauder outlook revised to stable by S&P on deleveraging

S&P Global Ratings revised Estee Lauder's outlook to stable from negative, citing improved operating results and credit metrics. The agency expects adjusted leverage to fall to 1.9x by fiscal 2027, with mid-single-digit revenue growth and expanded EBITDA margins. Cash flows are projected to decline due to restructuring and investments, but the company plans to use cash balances for debt repayment.

$ELHighAI 8/10

Estée Lauder (EL)’s China Bet Just Paid Off. Its Makeup Business Still Hasn’t Caught Up

Estée Lauder (EL) reported Q4 net sales of $3.63B, up 6.3%, driven by luxury fragrance and skincare. It forecasted fiscal 2027 adjusted EPS of $3.10-$3.35, above estimates, sending shares up 11% premarket. However, makeup sales were flat, and hair care dropped 1%. The company also reported a $38M tariff-refund benefit and a net loss of $116M, down from $546M a year earlier.

$ELMedAI 8/10

Estee Lauder vs Nike: One Turnaround Just Proved Itself, the Other Keeps Slipping

Estee Lauder (EL) reported four consecutive earnings beats, raising its fiscal 2027 EPS guidance to $3.10-$3.35. Nike (NKE) guided revenue down, with Greater China down 12% and Converse down 32%. EL's stock rose 10.46% post-earnings, while NKE's turnaround timeline extends. EL's forward P/E is near 32, with a 1.3% yield. NKE offers a 4.3% yield but faces declining revenue.